ArticleFrontiers in chemistry2026
Sustainable synthesis of quinazolinones: exploring multicomponent reactions with a novel magnetic palladium catalyst.
Article in Frontiers in chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study introduces a sustainable and efficient method for synthesizing quinazolinones, a class of heterocyclic compounds with significant pharmaceutical applications, via a multicomponent reaction (MCR) strategy. The process employs a novel magnetically recoverable palladium catalyst, enabling the coupling of aryl or heteroaryl iodides with a carbonyl source and 2-aminobenzamide in an eco-friendly PEG/water solvent system, facilitated by potassium carbonate as a base. The magnetic Pd catalyst exhibits robust catalytic activity, achieving high product yields (82%-98%) across diverse substrates, including electron-rich and electron-deficient aryl/heteroaryl iodides, underscoring its broad applicability. The catalyst is synthesized and characterized through various techniques, including FT-IR, BET, TGA, EDX, VSM, SEM, TEM, and XRD, which affirm its uniformity and stability. Key advantages of this protocol include exceptional atom economy, elimination of toxic solvents, and mild reaction conditions. The catalyst's magnetic properties allow effortless recovery via external magnetization, retaining >89% activity over five consecutive cycles, enhancing cost-effectiveness and sustainability. The methodology advances sustainable synthetic practices and holds promise for scalable applications in medicinal and industrial chemistry. This work highlights the transformative potential of magnetic nanocatalysts in developing eco-conscious routes to biologically relevant heterocycles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.